A seven year laboratory and clinical experience with lithium carbonate as an adjuvant to cancer chemotherapy.
D001854:Bone Marrow Cells; D002478:Cells, Cultured; D003561:Cytarabine / Q000494:pharmacology; D003630:Daunorubicin / Q000494:pharmacology; D004359:Drug Therapy, Combination; D006098:Granulocytes; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D007964:Leukocytosis / Q000139:chemically induced; D008094:Lithium / Q000494:pharmacology / Q000627:therapeutic use*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008727:Methotrexate / Q000494:pharmacology
D003561:Cytarabine; D008094:Lithium; D008727:Methotrexate; D003630:Daunorubicin